Aurobindo Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE406A01037
NSEID: AUROPHARMA
BSEID: 524804
View on NSE | View on BSE

INR

1,190.00

-1.15 (-0.1%)

BSENSE

Feb 09

BSE+NSE Vol: 8.12 lacs

{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,190.00",
    "chg": -1.15,
    "chgp": "-0.1%",
    "dir": -1,
    "prev_price": "1,191.15",
    "mcapval": "69,115.39 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE406A01037",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "8.12 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aurobindo Pharma Ltd: Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-valuation-shifts-signal-changing-price-attractiveness-3827693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_valuationdot_3827693.png",
        "date": "2026-02-09 08:00:17",
        "description": "Aurobindo Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group benchmarks."
      },
      {
        "title": "Aurobindo Pharma Ltd. Dips 1.74% Despite Early Week Surge: 4 Key Market Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-dips-174-despite-early-week-surge-4-key-market-moves-3827505",
        "imagepath": "",
        "date": "2026-02-08 15:01:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Technical momentum shifts to sideways trend amid consolidation</p>\n                    <p><strong>3 Feb:</strong> Strong gap-up opening and intraday high at Rs.1,247.05</p>\n                    <p><strong>4 Feb:</strong> Mildly bullish momentum emerges with mixed technical signals</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.1,191.15, down 1.74% from previous Friday</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,175.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div>..."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-3822205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_mojoScore_3822205.png",
        "date": "2026-02-05 10:10:38",
        "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Aurobindo Pharma Ltd. Exhibits Mildly Bullish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-exhibits-mildly-bullish-momentum-amid-mixed-technical-signals-3819489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_technicaldot_3819489.png",
        "date": "2026-02-04 08:00:36",
        "description": "Aurobindo Pharma Ltd. has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent price action and moving averages suggest a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aurobindo Pharma Ltd. Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3817632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_gapup_3817632.png",
        "date": "2026-02-03 09:39:56",
        "description": "Aurobindo Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.12% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aurobindo Pharma Ltd. Hits Intraday High with 5.05% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-intraday-high-with-505-surge-on-3-feb-2026-3817539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_priceRelatedfactors_3817539.png",
        "date": "2026-02-03 09:36:13",
        "description": "Aurobindo Pharma Ltd. demonstrated robust intraday strength on 3 Feb 2026, surging to an intraday high of Rs 1,247.05, marking a 6.12% gain from its previous close. The stock outperformed its sector and the broader market, reflecting strong buying momentum amid a mixed market backdrop."
      },
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Sideways Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-sideways-trend-3815224",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_technicaldot_3815224.png",
        "date": "2026-02-02 08:00:26",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent volatility. Key technical indicators such as MACD, RSI, and moving averages reveal a nuanced picture of the stock’s near-term prospects amid broader market pressures."
      },
      {
        "title": "Aurobindo Pharma Gains 6.98%: 3 Key Drivers Behind This Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-698-3-key-drivers-behind-this-weeks-momentum-3814784",
        "imagepath": "",
        "date": "2026-02-01 15:01:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock dips 0.26% amid broader Sensex gains</p>\n                    <p><strong>28 Jan:</strong> Recovery with 0.88% gain, Sensex up 1.12%</p>\n                    <p><strong>29 Jan:</strong> Continued gains of 0.91%, Sensex marginally up 0.22%</p>\n                    <p><strong>30 Jan:</strong> Sharp 5.37% rally on record volumes and derivatives surge</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,133.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,212.30</di..."
      },
      {
        "title": "Aurobindo Pharma Ltd: Valuation Shift Signals Caution Amidst Mixed Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-valuation-shift-signals-caution-amidst-mixed-market-performance-3813515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_valuationdot_3813515.png",
        "date": "2026-02-01 08:00:32",
        "description": "Aurobindo Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group."
      }
    ],
    "total": 716,
    "sid": "164981",
    "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Completion Of US FDA Inspection At Unit III Of Eugia Pharma Specialities Ltd. A Wholly Owned Subsidiary Of The Company",
      "datetime": "06-Feb-2026",
      "details": "Intimation of completion of US FDA inspection at Unit III of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Feb-2026",
      "details": "Intimation of participation in Nuvamas India Investor Conference to be held on February 11 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Feb-2026",
      "details": "Intimation of participation in Axis Capitals India Investor Conference to be held on February 12 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(09 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aurobindo Pharma Ltd: Valuation Shifts Signal Changing Price Attractiveness

2026-02-09 08:00:17

Aurobindo Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group benchmarks.

Read full news article

Aurobindo Pharma Ltd. Dips 1.74% Despite Early Week Surge: 4 Key Market Moves

2026-02-08 15:01:13

Key Events This Week

2 Feb: Technical momentum shifts to sideways trend amid consolidation

3 Feb: Strong gap-up opening and intraday high at Rs.1,247.05

4 Feb: Mildly bullish momentum emerges with mixed technical signals

6 Feb: Week closes at Rs.1,191.15, down 1.74% from previous Friday

Read full news article

Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO

2026-02-05 10:10:38

Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Aurobindo Pharma Ltd. Exhibits Mildly Bullish Momentum Amid Mixed Technical Signals

2026-02-04 08:00:36

Aurobindo Pharma Ltd. has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent price action and moving averages suggest a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Aurobindo Pharma Ltd. Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 09:39:56

Aurobindo Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.12% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector.

Read full news article

Aurobindo Pharma Ltd. Hits Intraday High with 5.05% Surge on 3 Feb 2026

2026-02-03 09:36:13

Aurobindo Pharma Ltd. demonstrated robust intraday strength on 3 Feb 2026, surging to an intraday high of Rs 1,247.05, marking a 6.12% gain from its previous close. The stock outperformed its sector and the broader market, reflecting strong buying momentum amid a mixed market backdrop.

Read full news article

Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Sideways Trend

2026-02-02 08:00:26

Aurobindo Pharma Ltd. has witnessed a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent volatility. Key technical indicators such as MACD, RSI, and moving averages reveal a nuanced picture of the stock’s near-term prospects amid broader market pressures.

Read full news article

Aurobindo Pharma Gains 6.98%: 3 Key Drivers Behind This Week’s Momentum

2026-02-01 15:01:12

Key Events This Week

27 Jan: Stock dips 0.26% amid broader Sensex gains

28 Jan: Recovery with 0.88% gain, Sensex up 1.12%

29 Jan: Continued gains of 0.91%, Sensex marginally up 0.22%

30 Jan: Sharp 5.37% rally on record volumes and derivatives surge

Week Open

Rs.1,133.15

Week Close

Rs.1,212.30Read full news article

Aurobindo Pharma Ltd: Valuation Shift Signals Caution Amidst Mixed Market Performance

2026-02-01 08:00:32

Aurobindo Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group.